Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for REDUZIERUNG DER IMMUNOGENITÄT GEGEN DEN FAKTOR VIII BEI PATIENTEN IN EINER FAKTOR-VIII-THERAPIE
Details for 2018183272
Up to date per 13.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2018183272
Title / Product Name
REDUZIERUNG DER IMMUNOGENITÄT GEGEN DEN FAKTOR VIII BEI PATIENTEN IN EINER FAKTOR-VIII-THERAPIE
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2018183272
EP Publication Number
3453402
E-Number
1411976
Language
EN
PCT Number
Publication Date
13.03.2019 A
21.07.2021 B1
Registration Date
21.07.2021
AT Publication Date
15.08.2021
Application Date
12.01.2013
Registration Number
-
Priorities
12.01.2012
US
201261586103 P
06.07.2012
US
201261668961 P
IPC
A61K 38/21 20060101AFI20201218BHEP
Maximum Duration of Protection
12.01.2033
Owner
Bioverativ Therapeutics Inc.
225 Second Avenue
Waltham MA 02451
US
Puget Sound Blood Center
921 Terry Avenue
Seattle, Washington 98104-1256
US
Representative
Representative
Häupl & Ellmeyer KG, Patentanwaltskanzlei
Mariahilfer Straße 50 (Eingang Kirchengasse 1)
1070 Wien
AT
Inventor
JIANG, Haiyan
3 Bayberry Lane
Belmont, MA Massachusetts 02478
US
LIU, Tongyao
53 Buckman Drive
Lexington, MA Massachusetts 02421
US
KRISHNAMOORTHY, Sriram
7 Martha Lane
Acton, MA Massachusetts 01720
US
JOSEPHSON, Neil
Puget Sound Blood Center 921 Terry Ave
Seattle, WA Washington 98104-1256
US
GLENN, Pierce
14 Cambridge Center
Cambridge, MA Massachusetts 02142
US
Information about Fees
Click here to load the fees